Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Complementary Medicines
Therapeutic Methods and Therapies TCIM
Database
Affiliation country
Publication year range
1.
Article in English | MEDLINE | ID: mdl-38290792

ABSTRACT

OBJECTIVE: Cartilage pathologic calcification is a hallmark of osteoarthritis (OA). Here, we aimed to describe a new ex vivo human model to study the progression of cartilage calcification. METHOD: Cartilage explants (n = 11), as well as primary chondrocytes (n = 3), were obtained from OA patients undergoing knee replacement. Explants and chondrocytes were cultured in control (NT) or calcification (CM) medium (supplemented with ascorbic acid and ß-glycerophosphate). Calcification was evaluated by micro-CT scan at day 0 and 21 in explants, and by Alizarin red staining in chondrocyte monolayers. Raman spectrometry allowed characterization of the crystal type. Interleukin-6 (IL-6) secretion in explant and cell supernatants was measured by ELISA. Finally, matrix degradation was evaluated by Safranin-O staining of explant sections and by glycosaminoglycans (GAG) release in supernatants. RESULTS: Micro-CT scan showed calcifications in all explants at baseline (day 0), which in the CM group increased significantly in number and size after 21 days compared with the NT group. Raman spectrometry revealed that crystals were exclusively basic calcium phosphate crystals (carbonated hydroxyapatite) both in NT and CM. IL-6 secretion was significantly increased in calcifying conditions. Finally, CM significantly increased cartilage catabolism as assessed by decreased Safranin-O staining of tissue explants and increased GAG release in supernatants. CM effects (enhanced calcification, IL-6 secretion and proteoglycans turn-over) were recapitulated in vitro in OA chondrocytes. CONCLUSIONS: We have described a new ex vivo human model of cartilage calcification that can summurize the triad of events seen during osteoarthritis progression, i.e. calcification, inflammation, and cartilage degradation. This model will allow the identification of new anti-calcification compounds.

2.
EBioMedicine ; 81: 104081, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35660787

ABSTRACT

BACKGROUND: Cartilage damage in inflammatory arthritis is attributed to inflammatory cytokines and pannus infiltration. Activation of the coagulation system is a well known feature of arthritis, especially in rheumatoid arthritis (RA). Here we describe mechanisms by which fibrin directly mediates cartilage degeneration. METHODS: Fibrin deposits were stained on cartilage and synovial tissue of RA and osteoarthritis (OA) patients and in murine adjuvant-induced arthritis (AIA) in wild-type or fibrinogen deficient mice. Fibrinogen expression and procoagulant activity in chondrocytes were evaluated using qRT-PCR analysis and turbidimetry. Chondro-synovial adhesion was studied in co-cultures of human RA cartilage and synoviocytes, and in the AIA model. Calcific deposits were stained in human RA and OA cartilage and in vitro in fibrinogen-stimulated chondrocytes. FINDINGS: Fibrin deposits on cartilage correlated with the severity of cartilage damage in human RA explants and in AIA in wild-type mice, whilst fibrinogen deficient mice were protected. Fibrin upregulated Adamts5 and Mmp13 in chondrocytes. Chondro-synovial adhesion only occurred in fibrin-rich cartilage areas and correlated with cartilage damage. In vitro, autologous human synoviocytes, cultured on RA cartilage explants, adhered exclusively to fibrin-rich areas. Fibrin co-localized with calcification in human RA cartilage and triggered chondrocyte mineralization by inducing pro-calcification genes (Anx5, Pit1, Pc1) and the IL-6 cytokine. Similar fibrin-mediated mechanisms were observed in OA models, but to a lesser extent and without pseudo-membranes formation. INTERPRETATION: In arthritis, fibrin plaques directly impair cartilage integrity via a triad of catabolism, adhesion, and calcification. FUNDING: None.


Subject(s)
Arthritis, Rheumatoid , Osteoarthritis , Animals , Arthritis, Rheumatoid/metabolism , Cartilage/metabolism , Chondrocytes/metabolism , Fibrin/metabolism , Fibrinogen/genetics , Fibrinogen/metabolism , Humans , Mice , Osteoarthritis/genetics , Osteoarthritis/metabolism , Synovial Membrane
3.
Clin Exp Rheumatol ; 30(2): 240-5, 2012.
Article in English | MEDLINE | ID: mdl-22410098

ABSTRACT

OBJECTIVES: Currently there are no reliable biomarkers in the synovial fluid available to differentiate between septic and non-septic arthritis or to predict the prognosis of osteoarthritis, respectively. Nuclear magnetic resonance (NMR) spectroscopy is an analytical technique that allows a rapid, high throughput metabolic profiling of biological fluids or tissues. METHODS: Proton (1H)-nuclear magnetic resonance (NMR) spectroscopy was performed in synovial fluid samples from patients with septic arthritis, crystal arthropathy, different forms of inflammatory arthritis or osteoarthritis (OA). The metabolic environment based on the low molecular weight components was compared in disease subsets and principal component analysis (PCA) was performed. RESULTS: Fifty-nine samples from patients with OA, gout, calcium pyrophosphate disease, spondylarthritis, septic arthritis and rheumatoid arthritis (RA) were analysed. NMR yielded stable and reproducible metabolites over time. Thirty-five different metabolites as well as paracetamol and ibuprofen were identified in synovial fluid. The metabolic profile of septic arthritis assessed by PCA was distinguishable from the other samples whereas no differences were seen in OA compared to crystal-associated arthritis, RA or spondylarthritis. CONCLUSIONS: 1H-NMR is a fast analytic tool with possible implications in synovial fluid diagnostics. A distinctive metabolism is observed in septic arthritis whereas metabolites in OA are similar to those in inflammatory arthritis.


Subject(s)
Arthritis/metabolism , Magnetic Resonance Spectroscopy , Metabolomics/methods , Synovial Fluid/metabolism , Arthritis/drug therapy , Arthritis, Infectious/metabolism , Arthritis, Rheumatoid/metabolism , Biomarkers/metabolism , Gout/metabolism , Humans , Molecular Weight , Multivariate Analysis , Osteoarthritis/metabolism , Paracentesis , Pilot Projects , Principal Component Analysis , Spondylarthropathies/metabolism
4.
Med Klin (Munich) ; 99(10): 626-9, 2004 Oct 15.
Article in German | MEDLINE | ID: mdl-15490078

ABSTRACT

BACKGROUND: Syncope is a frequent reason for hospital admissions or emergency department visits with a broad differential diagnosis. Convulsive syncope is often falsely interpreted as an epileptic disorder. However, due to cerebral hypoperfusion, all forms of syncope can be associated with convulsions. In elderly patients with coronary heart disease or hypertension, "neurocardiogenic" causes, especially the carotid sinus syndrome, should be searched for. In general, cardiac pauses > or = 3 s after massage of the carotid sinus are required for the diagnosis of inhibitory carotid sinus syndrome. CASE REPORT: In the patient presented here, massage of the right carotid sinus provoked sinus bradycardia with pauses of 2,2 s and subsequent convulsive syncope. CONCLUSION: Additive factors such as coronary heart disease, arteriosclerosis, heart failure, and antihypertensive therapy may result in early symptoms of the inhibitory carotid sinus syndrome. This underlines the multifactorial pathogenesis of syncope, especially in the elderly patient.


Subject(s)
Carotid Sinus/physiopathology , Seizures/etiology , Syncope/etiology , Age Factors , Aged , Bradycardia/etiology , Carotid Artery Diseases/diagnosis , Diagnosis, Differential , Electrocardiography , Electroencephalography , Follow-Up Studies , Humans , Male , Massage , Myocardial Ischemia/complications , Pacemaker, Artificial , Syncope/diagnosis , Syndrome , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL